Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Falkai

Showing results (71-80 of 756) with videos related to

Pageof 76
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|May 30, 2015
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosisAndrea Schmitt, Peter Falkai
European Archives of Psychiatry and Clinical Neuroscience|November 26, 2010
Sleep, hypothalamus, and stigmaPeter Falkai, Hans-Jürgen Möller
European Archives of Psychiatry and Clinical Neuroscience|May 18, 2012
From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficitsPeter Falkai, Hans-Jürgen Möller
The Australian and New Zealand Journal of Psychiatry|October 28, 2020
Changes in antidepressant therapy should be considered early in patients with inadequate response to a first-line agentBernhard T Baune, Peter Falkai
European Archives of Psychiatry and Clinical Neuroscience|June 30, 2012
Biomarkers and neurobiology of schizophreniaPeter Falkai, Hans-Jürgen Möller
MMW Fortschritte Der Medizin|January 24, 2012
[Sexual abuse and the consequences. This concerns all doctors]Peter Falkai, Jörg M Fegert
European Archives of Psychiatry and Clinical Neuroscience|March 28, 2012
Psychopathology: genetics and the stress-vulnerability hypothesisPeter Falkai, Hans-Jürgen Möller
European Archives of Psychiatry and Clinical Neuroscience|September 17, 2010
Understanding mental disorders from neuronal networks to glial cells and proteomicsPeter Falkai, Hans-Jürgen Möller
Frontiers in Psychiatry|September 6, 2023
Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume IIPeter Falkai, Zsófia Borbála Dombi
European Archives of Psychiatry and Clinical Neuroscience|February 15, 2023
Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella reviewHans-Jürgen Möller, Peter Falkai
Pageof 76

Showing results (71-80 of 756) with videos related to

Sort By:
Pageof 76
European Archives of Psychiatry and Clinical Neuroscience|May 30, 2015
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosisAndrea Schmitt, Peter Falkai
European Archives of Psychiatry and Clinical Neuroscience|November 26, 2010
Sleep, hypothalamus, and stigmaPeter Falkai, Hans-Jürgen Möller
European Archives of Psychiatry and Clinical Neuroscience|May 18, 2012
From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficitsPeter Falkai, Hans-Jürgen Möller
The Australian and New Zealand Journal of Psychiatry|October 28, 2020
Changes in antidepressant therapy should be considered early in patients with inadequate response to a first-line agentBernhard T Baune, Peter Falkai
European Archives of Psychiatry and Clinical Neuroscience|June 30, 2012
Biomarkers and neurobiology of schizophreniaPeter Falkai, Hans-Jürgen Möller
MMW Fortschritte Der Medizin|January 24, 2012
[Sexual abuse and the consequences. This concerns all doctors]Peter Falkai, Jörg M Fegert
European Archives of Psychiatry and Clinical Neuroscience|March 28, 2012
Psychopathology: genetics and the stress-vulnerability hypothesisPeter Falkai, Hans-Jürgen Möller
European Archives of Psychiatry and Clinical Neuroscience|September 17, 2010
Understanding mental disorders from neuronal networks to glial cells and proteomicsPeter Falkai, Hans-Jürgen Möller
Frontiers in Psychiatry|September 6, 2023
Editorial: Community series in novel antipsychotics within and beyond clinical trials: symptom-based treatment of psychiatric disorders with D3-D2 partial agonists, volume IIPeter Falkai, Zsófia Borbála Dombi
European Archives of Psychiatry and Clinical Neuroscience|February 15, 2023
Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella reviewHans-Jürgen Möller, Peter Falkai
Pageof 76